MyBlueDotsAspect Biosystems Raises US$115 Million Series B Financing to Advance Bioprinted Tissue Therapeutics MyBlueDots5 months ago01 mins VANCOUVER, British Columbia–(BUSINESS WIRE)– #biotech–Aspect Biosystems secures $115M Series B to advance bioprinted tissue therapeutics, accelerating development of functional cures for serious diseases Post navigation Previous: Resumen: Biocytogen y Acepodia combinan fuerzas para desarrollar anticuerpos biespecíficos y ADC de carga doble para el tratamiento de tumores complejosNext: NorthStar Medical Radioisotopes and YAP Therapeutics Enter into Collaboration Agreement for the Development and Production of Radiopharmaceutical Products
‘Master control switch’ protein that heightens neurodegenerative disease offers new treatment target MyBlueDots2 days ago 0
New findings reveal how the heart is organized from the earliest stages of embryonic development MyBlueDots2 days ago 0
Scholastic performance is a key concern for young cancer patients, study finds MyBlueDots2 days ago 0